Ki Summary

Reaction Details

Report a problem with these data

Target

Neuropeptide Y receptor type 5

Ligand

BDBM50304315

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_606453 (CHEMBL1074018)

IC50

0.89±n/a nM

Citation

Haga, Y; Sakamoto, T; Shibata, T; Nonoshita, K; Ishikawa, M; Suga, T; Takahashi, H; Takahashi, T; Takahashi, H; Ando, M; Murai, T; Gomori, A; Oda, Z; Kitazawa, H; Mitobe, Y; Kanesaka, M; Ohe, T; Iwaasa, H; Ishii, Y; Ishihara, A; Kanatani, A; Fukami, T Discovery of trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1'-cyclohexane]-4'-carboxamide, a potent and orally active neuropeptide Y Y5 receptor antagonist. Bioorg Med Chem17:6971-82 (2009) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Neuropeptide Y receptor type 5

Name:

Neuropeptide Y receptor type 5

Synonyms:

Type:

Enzyme

Mol. Mass.:

50746.64

Organism:

Homo sapiens (Human)

Description:

Q15761

Residue:

445

Sequence:

MDLELDEYYNKTLATENNTAATRNSDFPVWDDYKSSVDDLQYFLIGLYTFVSLLGFMGNL
LILMALMKKRNQKTTVNFLIGNLAFSDILVVLFCSPFTLTSVLLDQWMFGKVMCHIMPFL
QCVSVLVSTLILISIAIVRYHMIKHPISNNLTANHGYFLIATVWTLGFAICSPLPVFHSL
VELQETFGSALLSSRYLCVESWPSDSYRIAFTISLLLVQYILPLVCLTVSHTSVCRSISC
GLSNKENRLEENEMINLTLHPSKKSGPQVKLSGSHKWSYSFIKKHRRRYSKKTACVLPAP
ERPSQENHSRILPENFGSVRSQLSSSSKFIPGVPTCFEIKPEENSDVHELRVKRSVTRIK
KRSRSVFYRLTILILVFAVSWMPLHLFHVVTDFNDNLISNRHFKLVYCICHLLGMMSCCL
NPILYGFLNNGIKADLVSLIHCLHM

BDBM50304315

n/a

Name

BDBM50304315

Synonyms:

CHEMBL593465 | trans-3-Oxo-N-(2-phenyl-2H-1,2,3-triazol-4-yl)-3Hspiro[6-aza-2-benzofuran-1,1'-cyclohexane]-4'-carboxamide

Type

Small organic molecule

Emp. Form.

C21H19N5O3

Mol. Mass.

389.4073

SMILES

O=C(Nc1cnn(n1)-c1ccccc1)[C@H]1CC[C@@]2(CC1)OC(=O)c1ccncc21 |r,wU:17.22,wD:14.15,(-4.09,-21.75,;-3.32,-23.08,;-1.78,-23.08,;-.88,-24.33,;.67,-24.33,;1.14,-25.79,;-.1,-26.7,;-1.35,-25.79,;-.1,-28.23,;-1.44,-29,;-1.44,-30.53,;-.11,-31.31,;1.23,-30.53,;1.23,-28.99,;-4.09,-24.41,;-5.63,-24.41,;-6.41,-25.75,;-5.63,-27.07,;-4.09,-27.07,;-3.33,-25.75,;-4.71,-28.33,;-5.62,-29.59,;-5.15,-31.05,;-7.1,-29.11,;-8.43,-29.88,;-9.77,-29.11,;-9.76,-27.56,;-8.43,-26.79,;-7.1,-27.56,)|

Structure